Endoscopy Devices Industry Is Expected To Grow As Of The Rising Burden Of Chronic Diseases

 

 

Endoscopy devices industry data book covers endoscopes, endoscopy visualization system, endoscopy visualization component and endoscopy operative devices market.

The global endoscopy devices market was valued at USD 50.8 Billion in 2022 and is anticipated to grow at a CAGR of 7.5% over the forecast period.

Grand View Research’s endoscopy devices industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with an endoscopy devices statistics e-book.

Endoscopes Market Insights

The global endoscopes market was valued at USD 18.8 Billion in 2022 and is anticipated to grow at a CAGR of 9.0% over the forecast period. The rise in prevalence of chronic disorders and the growing awareness of early detection of diseases through minimally invasive surgical procedures are some of the major factors anticipated to drive the market growth over the forecast years. In addition, favorable reimbursement policies, and increasing FDA approvals for endoscopic devices are also expected to boost the growth of the market over the years. For instance, in 2021, the United States Food and Drug Administration granted 510(k) clearance to EndoFresh’s disposable digestive endoscopy system, a device developed to reduce the chance of contamination in gastrointestinal procedures.

North America led the market in 2022 and accounted for the highest share of more than 41.4% of the global revenue. The regional market is estimated to retain the dominant position throughout the forecast period owing to the increasing adoption of elective endoscopic procedures, improved healthcare expenditure, and the high geriatric population. In addition, the high burden of cancer and functional gastrointestinal disorders in the U.S. is anticipated to further drive the market over the forecast period. Asia Pacific is projected to be the fastest-growing regional market over the forecast period. This growth is owing to the presence of a large patient population pool suffering from functional gastrointestinal disorders.

Endoscopy Visualization Component Market insights

The global endoscopy visualization component market was valued at USD 6.7 Billion in 2022 and is anticipated to grow at a CAGR of 7.0% over the forecast period. A significant increase in the number of endoscopic operations, as well as an increasing demand for minimally invasive treatments, are primary factors driving market growth. Endoscopy is becoming more popular due to its advantages over invasive procedures, significant cost savings, and favorable government reimbursement schemes. Furthermore, the increasing adoption of new diagnostic instruments has resulted in an increased demand for advanced visualization approaches. As a result, several manufacturers are emphasizing the introduction of components with enhanced visualization capabilities.

Order Free Sample Copy of Endoscopy Devices Industry Data Book, published by Grand View Research

Endoscopy Visualization System Market Insights

The global endoscopy visualization system market was valued at USD 16.7 Billion in 2022 and is anticipated to grow at a CAGR of 6.8% over the forecast period. Endoscopy is a minimally invasive procedure used for the examination of the internal organs in the body. Visualization systems with advanced technologies can provide superior image quality, which makes them very important in the medical field. In recent years, endoscopic procedures have emerged as a potential adjunctive tool in various medical specialties such as general surgery, gastrointestinal, urology, and others. According to the Centers for Disease Control and Prevention, around 494,000 hysterectomies are performed in the U.S. annually. Approximately 80.0% of the surgeries are done laparoscopically or robotically. Thus, shift towards minimally invasive surgeries and increasing prevalence of cancer, thereby fueling the market growth.

North America dominated the endoscopy visualization systems market and accounted for the largest revenue share of 43.3% in 2020. The rapid adoption of minimally invasive procedures, high prevalence of gastric and colorectal cancer, and growing demand for advanced diagnostic tools are factors attributable to the dominant share of the region in the market. Asia Pacific is projected to witness remarkable growth over the forecast period owing to the high presence of age population in Asian countries such as China, India, and others. In Europe, the market is poised to surge owing to the rising cost burden of cancer and the growing number of endoscopic procedures.

Endoscopy Operative Devices Market Insights

The global endoscopy operative devices market was valued at USD 8.6 Billion in 2022 and is anticipated to grow at a CAGR of 5.7% over the forecast period. The increasing prevalence of chronic disorders, such as obesity, diabetes, and cancer, coupled with the growing geriatric population, is expected to boost the demand for endoscopies. The rising awareness regarding the benefits associated with minimally invasive procedures, such as lesser post-operative complications and shortened hospitalization and recovery time, is further surging the demand for these procedures. The rising incidence of urological, respiratory, gastrointestinal, and gynecological disorders requiring endoscopy for diagnosing and treating the disorders is expected to propel the market growth.

North America accounted for the largest revenue share of over 40.0% in 2020 due to the growing prevalence of cancer and other chronic disorders. The growing preference for minimally invasive procedures using advanced endoscopy operative devices is contributing to the market growth. In addition, the growing demand for endoscopies for diagnostic and therapeutic purposes is propelling the market growth. Asia Pacific is anticipated to register the fastest growth rate during the forecast period due to the growing economies of India and China and rising disposable income in these countries. The increasing prevalence of chronic disorders, growing geriatric population, developing healthcare infrastructure, and the introduction of advanced endoscopic procedures are expected to drive the Asia Pacific market over the forecast period.

Go through the table of content of Endoscopy Devices Industry Data Book to get a better understanding of the Coverage & Scope of the study.

Endoscopy Devices Industry Data Book Competitive Landscape

Increasing demand for endoscopy devices is increasing competition in the market and, thus, forcing key players to introduce new products in the market. Additionally, it is projected that rising industry consolidation activities, such as acquisitions and mergers by the leading market participants, as well as expanding efforts in R&D of endoscopy device applications by key players, are also expected to boost the market share.

Key players operating in the endoscopy devices industry are –

• Olympus Corporation
• Ethicon Endo-surgery, LLC.
• FUJIFILM Holdings Corporation
• Stryker Corporation
• Boston Scientific Corporation
• Karl Storz GmbH & Co. KG
• Smith & Nephew Inc.
• Richard Wolf GmbH
• Medtronic Plc (Covidien)
• PENTAX Medical
• Machida Endoscope Co., Ltd

Cosmetic Dental Products Industry Is Expected To Expand At A CAGR Of 7.4% From 2023 To 2030

 Cosmetic Dental Products Industry Data Book Covers Teeth Whitening, Dental Implants, Dental Crown & Bridges and Dental Veneers Market.

The global Cosmetic Dental Products Industry was estimated at USD 21.0 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.4% from 2023 to 2030.

Grand View Research, Cosmetic Dental Products industry databook collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. 

Teeth Whitening Market Insights

The global teeth whitening market size was estimated at USD 6.9 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.0% from 2022 to 2030. With an increase in the population opting for the improvement of dental aesthetics, this industry has undergone great advancements. Developing countries have generated a large amount of disposable income which is the main reason why the market is flourishing. The geriatric population, in general, has propagated the growth of this industry with old age-related tooth ailments. Factors such as the increasing popularity of cosmetic dentistry, evolving medical tourism of dental treatment, and the introduction of multiple government initiatives for public oral health care, are few growth enablers for the market.

The industry is led by North America with a revenue share of around 37% in 2021, owing to the technological advancement and increase in the number of individuals opting for procedures involved in the teeth whitening market. The region has high awareness regarding oral health and the people opting for cosmetic procedures have also seen a surge. Asia Pacific is set to grow tremendously with the highest CAGR during the forecast period. This is mainly due to the increasing amount of disposable income that is being generated in developing countries like India and China.

Dental Implants Market Insights

The global dental implants market size was valued at USD 4.6 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2023 to 2030. Increasing applications of dental implants in various therapeutic areas along with rising demand for prosthetics are some of the key factors expected to boost the industry growth. Prosthetics play a major role in propelling the demand for these implants through oral rehabilitation, which helps in restoring the oral function and facial form of a patient. Acceptance level for dental implants is increasing among patients and dental surgeons due to limitations of removable prosthetics, such as discomfort, lack of natural appearance, and need for maintenance.

In 2022, North America dominated the global industry and accounted for the maximum share of more than 35.50% of the overall revenue. The prominent drivers of the region include the growing geriatric population with a high incidence of dental conditions and high awareness among the population regarding oral preventive & restorative treatments in this region. Asia Pacific is anticipated to be the fastest-growing region over the forecast period owing to increasing economic stability and disposable income. Asian countries have dense populations, with a growing burden of geriatric population.

Order your copy of the Free Sample of Cosmetic Dental Products Industry Data Book, published by Grand View Research

Dental Crown & Bridges Market insights

The global dental crowns and bridges market size was valued at USD 2.1 billion in 2018 and is expected to expand a CAGR of 7.78% by 2026. Factors such as rising prevalence of dental disorders, high demand for cosmetic dentistry, and growing dental medical tourism in the developing economies are anticipated to majorly influence the growth. Dental crowns and bridges are the prosthetic devices used for dental restoration. They are fixed on the damaged tooth with dental cement that helps improve the strength and overall appearance of the tooth. Rising awareness regarding cosmetic dentistry is anticipated to bode well for the overall growth in the near future.

Rise in demand for preventive and cosmetic dentistry is expected to drive the market significantly during the forecast period. In addition, the introduction of novel technologies, such as CAD/CAM is anticipated to stimulate growth. This technology is expected to gain popularity in near future since it improves the creation and design of dental restorations.

North America economies, such as Canada and U.S. are expected to hold a significant market share owing to the supportive reimbursement policies. Asia Pacific is projected to hold a larger market share during the forecast period due to efforts by manufacturers to promote their products and expand their customer base.

Dental Veneers Market Insights

The global dental veneers market size was valued at USD 2.1 billion in 2021 and is expected to expand at a CAGR of 8.3% during the forecast period. The rapidly increasing demand for cosmetic procedures in dentistry is driving awareness about the products such as dental veneers. The rising occurrence of dental ailments, growing demand for restorative dental procedures, emerging dental tourism worldwide, and growing expendable income in developing countries are some of the key driving factors contributing to market growth. The dental care sector was significantly impacted at the beginning of the COVID-19 pandemic owing to the government-imposed social distancing guidelines.

North America dominated the market and accounted for revenue share of 48.7% in 2021 due to the growth of the geriatric American population. Asia Pacific, the market is anticipated to witness the fastest CAGR of 9.6% during the forecast period. Owing to the increasing medical tourism, growing awareness related to dental health, and rising R&D activities, Asia Pacific dental veneers market is likely to have rapid growth. The infrastructure of medical care in Asia pacific is developing with the availability of advanced medical equipment.

Go through the table of content of Cosmetic Dental Products Industry Data Book to get a better understanding of the Coverage & Scope of the study.

Cosmetic Dental Products Industry Data Book Competitive Landscape

Companies are focusing on strategic initiatives, such as the introduction of novel products through customization according to consumers’ needs, partnerships, collaborations, and mergers & acquisitions, to expand their product portfolio and extend leadership positions in the field of dental implantology.

Key players operating in the cosmetic dental products industry are –

• Colgate Palmolive
• GlaxoSmithKline Plc
• Johnson & Johnson.
• Procter & Gamble
• Brodie & Stone
• Unilever.
• Church & Dwight Co.
• Institut Straumann
• Envista Holding Corporation (Nobel Biocare Services AG)
• Biohorizons IPH, Inc.
• Zimmer Biomet
• Dentsply Sirona
• Dentium.
• Henry Schein Inc
• 3M Health Care.
• OSSTEM Implant.
• Glidewell Laboratories
• Coltene
• Ultradent Products Inc.

 

Breast Pump And Breastfeeding Accessories Industry To Grow Up As Of Rise In The Global Women’s Employment Rate

 Breast pump and breastfeeding accessories industry data book covers breast pump, wearable breast pump & breastfeeding accessories market.

The global Breast Pump And Breastfeeding Accessories Industry generated over USD 4.06 billion in 2021 and is projected to expand at a CAGR of around 8.3% during the forecast period.

Grand View Research’s breast pump & breastfeeding accessories industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research. The following data points will be included in the final product offering in 3 reports and one sector report overview:

Breast Pump Market Insights

The global breast pump market generated over USD 1.84 billion in 2021 and is projected to expand at a CAGR of around 8.3% during the forecast period. The key factors driving market growth include rising global women's employment rates, improved healthcare infrastructure in emerging economies, and government initiatives to support working mothers. The International Labor Organization (ILO) reports that there has been visible progress in terms of employment opportunities and gender equality over the last 20 years. The ILO initiated the 2030 United Nations Agenda, which declares that the genders of youth and the disabled population are likely to have equal pay without discrimination in order to achieve gender equality and empower all women and girls in order to achieve productive employment, gender equality, and economic development.

North America dominated the industry with a market share of 52.69% in 2022 and is expected to witness a considerable growth rate of 8.2% during the forecast period. North America dominated the overall market in terms of revenue share majorly due to increased market penetration of breast pumps in this region, on account of the presence of high women employment rates, healthcare expenditure, sophisticated healthcare infrastructure, and patient awareness levels. Europe captured more than 24% of revenue share in 2022 owing to the growing birth rate coupled with rising women's employment in the region.

Wearable Breast Pump Market Insights

The global wearable breast pump market generated over USD 350 million in 2021 and is projected to expand at a CAGR of around 8.2% from 2022 to 2030. A worldwide surge in women’s employment rate is expected to increase the demand for wearable breast pumps. For instance, as per International Labor Office, in 2018 the women employment rate in developed countries was 52.4% which further increased in developing countries with 69.3%. Similarly, the women employment rate in Sub-Saharan Africa region has also increased to 64.7%. Working women have a relatively high disposable income and less time to breastfeed their babies and thus, are ideal customers for wearable breast pumps.

Order your copy of the Free Sample of “Breast Pump And Breastfeeding Accessories Industry Data Book” published by Grand View Research

Breastfeeding Accessories Market insights

The global breastfeeding accessories market generated over USD 2.2 billion in 2021 and is projected to expand at a CAGR of around 6.4% from 2022 to 2030. The demand for breastfeeding accessories is increasing owing to a rise in the global women’s employment rate. Furthermore, an increase in awareness campaigns by government and market players regarding the availability of breastfeeding accessories is anticipated to impel the market growth during the forecast period.

North America dominated the wearable breast pump market with a market share of 52.4% in 2022. This dominance can be attributed to increasing in various government initiatives. For instance, various awareness campaigns by CDC, WHO, and ABM to feed babies with expressed breastmilk using breast pumps is expected to have a positive impact on the market. Moreover, CDC has been encouraging women to feed babies with breast milk. In addition, CDC has also laid guidelines & recommendations regarding the proper storage and preparation of breast milk on their website, which is anticipated to increase awareness regarding the importance of breast milk among women, thereby impelling the market growth. Asia Pacific is anticipated to witness the fastest growth of 10.4% during the forecast period. This can be attributed to the well-established healthcare facilities, government support, and a decrease in infant mortality rate.

Similarly, an increasing number of milk banks around the globe is predicted to propel market growth further. Due to the high demand for breast milk storage, the number of milk banks is increasing. Milk banks are beneficial for mothers and are considered a progressive initiative. If the mother is infected and there is a risk of disease transmission, the mother is unable to lactate, or the baby is orphaned, milk banks can offer major advantages. Thus, an increase in the number of milk banks may increase the use of breastfeeding accessories, thereby driving the market over the forecast period.

Asia Pacific dominated the market with a revenue share of over 42.8% in 2022. This can be attributed to the presence of a large target audience and increasing awareness campaigns in this region. Moreover, an increase in the birth rate is expected to help the market grow in this region. For instance, as per Work Bank, the birth rate in China has increased to 1.70 births per woman in 2019 from 1.60 in 2000. The Middle East and Africa region are estimated to register the highest CAGR of 6.71% during the forecast period. This can be attributed to the changing lifestyles leading to various diseases.

Go through the table of content of Breast Pump And Breastfeeding Accessories Industry Data Book to get a better understanding of the Coverage & Scope of the study.

Breast Pump And Breastfeeding Accessories Industry Data Book Competitive Landscape

The market players are focused on research and development activities to develop technologically advanced products to gain a competitive edge. In addition, strategies such as marketing and promotions are widely used by companies operating in this market to increase awareness about the benefits of breastfeeding, educate, encourage, and support nursing mothers, and also to increase the availability and outreach of their component offerings.

Key players operating in the breast pump and breastfeeding accessories industry are –

• Medela LLC
• Laura & Co.
• Newell Brands
• Ameda
• Hygeia Health
• Koninklijke Philips N.V.
• Lansinoh Laboratories, Inc.
• Pigeon Corporation
• Motif Medical
• Chiaro Technology Limited (Elvie)
• Willow Innovations, Inc.
• Spectra Baby Usa
• Lavie MOM
• MAYBORN GROUP LIMITED
• Elvie
• Freemie
• BabyBuddha Product, LLC
• iAPOY

Ultrasound Devices And Accessories Industry To Go Above Due To Rising Demand For Minimally Invasive Surgical Procedures

 Ultrasound devices and accessories industry data book covers ultrasound device, ultrasound transducer and ultrasound gels market.

The global Ultrasound Devices and Accessories Industry was valued at USD 13.65 billion in 2022 and is anticipated to expand at a CAGR of 4.4% from 2023 to 2030.

 

Grand View Research’s Ultrasound devices and accessories industry databook is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

 

Ultrasound Device Market Insights

The global ultrasound device market size was estimated at USD 10.2 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 4.3% from 2023 to 2030. The market growth is anticipated to be driven by the rising use of ultrasound equipment for diagnostic imaging and treatment, as well as the rising prevalence of chronic and lifestyle-related diseases. A few of the major factors influencing the market include the increased demand for minimally invasive surgery and developments in ultrasound imaging technology. Ultrasound is considered one of the most valuable diagnostic tools in medical imaging when compared to other diagnostic imaging systems since it is both faster and less expensive. In addition, as it does not use magnetic fields or ionizing radiation, it is safer than other imaging technologies. Both diagnostic and therapeutic uses for ultrasonic medical devices are extensive. Specific therapeutic applications of ultrasound, from oncology to cardiology, have grown in popularity.

 

North America dominated the market in 2022 with the largest revenue share of over 30.04%. Over the forecast period, the region is expected to grow at a significant rate. The presence of a significant number of market competitors in the region and the increasing number of cancer cases are some of the key factors contributing to the regional market growth. Furthermore, increasing incidence of cancer cases drives the market growth in this region. For instance, as per the National Journal of Health Statistics, in 2023, in the United States, 195,831 additional cases of cancer and 60,982 fatalities due to cancer are anticipated. Furthermore, increasing expenditure on health care, greater understanding of various methods of diagnosis, and favorable policies for reimbursement are projected to drive market expansion in this area.

 

Ultrasound Transducer Market Insights

The global ultrasound transducer market size was valued at USD 3.3 billion in 2022 and is expected to expand at a CAGR of 4.8% from 2023 to 2030. Increasing applications of ultrasound devices in diagnostic imaging of various conditions and the introduction of advanced transducers are some of the major factors driving the growth.

The rising frequency of product launches is expected to propel the ultrasound transducer market. Key players are focusing on the development of high-powered, handheld, single-use ultrasound transducers. Moreover, companies are launching ultrasound devices incorporated with the advanced transducer. These advanced products are specially designed for various applications including vascular and muscular-skeletal. Introduction of novel devices such as EPIQ Elite ultrasound system, SiliconWave L38-22 linear array transducer, and mi-ultra with both linear & convex offering is anticipated to boost the market during the forecast period.

North America is anticipated to lead the market owing to the high adoption of ultrasound modality in general diagnostics and the rising prevalence of lifestyle-associated chronic diseases. Also, high demand for technologically advanced medical devices is expected to propel the market growth in the region.
The Asia Pacific is anticipated to grow significantly in the forthcoming years owing to the rapidly growing geriatric population, improving healthcare facilities for treating heart disorders, and growing healthcare expenditure. Blooming medical tourism in Asia Pacific economies is also expected to fuel the ultrasound transducer market in the region.

 

Order your copy of the Free Sample of “Ultrasound Devices and Accessories Industry Data Book - Ultrasound Device, Ultrasound Transducer and Ultrasound Gels Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

 

Ultrasound Gels Market insights

 

The global ultrasound gel market size was valued at USD 101.5 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 2.6% from 2023 to 2030. An aqueous media is required to be placed in between the ultrasound probe and the skin to obtain a clear image. Ultrasound gel is used as an aqueous media that acts as a coupling agent in these procedures. Its compositions are Carbopol, propylene glycol, phenoxyethanol, glycerin, dyes, perfume, and water. They are formulated in different proportions and compositions depending on the manufacturer, and the recipes are proprietary. Ultrasound gel, an inevitable component during the ultrasound scan, is facing high demand from healthcare facilities. Thus, the increasing procedural volume of ultrasound worldwide is expected to drive the market's growth. In addition, the rising adoption of ultrasound devices in point-of-care diagnostic and bedside monitoring can further propel the growth of this market.

North America dominated the market and accounted for the largest revenue share of 39.2% in 2022. The factors such as the presence of major market players, developed healthcare infrastructure, and streamlined reimbursement policies are expected to drive the regional market growth. In addition, the increasing acceptance of ultrasound at community-level clinics and home healthcare is expected to aid market growth.

Europe held the second-largest market share. Huge consumption of medical consumables, growing healthcare expenditure, and rising medical imaging procedures are anticipated to drive the market in the region. According to the annual statistics released by the National Health Service (NHS), from March 2022 to February 2023, over 43.0 million imaging tests were reported in England, out of which 3.33 million imaging tests were reported to have taken place in February 2023, and 0.78 million of these were diagnostic ultrasonography.

Asia Pacific is expected to grow at the fastest CAGR of 3.8% during the forecast period. Large unmet needs, developing healthcare facilities, and the presence of several small-scale domestic manufacturers, especially in countries such as China and India, are expected to boost market growth. TELE-PAPER Malaysia, one of Asia's largest thermal product manufacturers, introduced SONOMED ULTRASOUND GEL, a filtered water-based gel that can be used with any ultrasonic device

Go through the table of content of Ultrasound Devices and Accessories Industry Data Book to get a better understanding of the Coverage & Scope of the study.

 

Ultrasound Devices and Accessories Industry Data Book Competitive Landscape

The major players are working to improve their product offerings by upgrading their products, taking advantage of important cooperation activities, and exploring acquisitions and government clearances in order to expand their customer base and gain a larger share of the overall market.

Key players operating in the ultrasound devices and accessories industry are –

• Compass Health Brands
• ECO-MED
• National Therapy Products
• H.R Pharmaceuticals Inc
• Tele-Paper Malaysia
• Sonogel Vertriebs
• Medline Industries, Inc
• Parker Laboratories
• Ultragel Kft.

 

 

 

Advanced Wound Dressing Products Industry To Boost Due To Increasing Number Of Surgical Procedures

  

Advanced wound dressing products industry data book covers foam dressings, hydrocolloid dressings, film dressings, alginate dressings, hydrogel dressings and collagen dressings market.

Grand View Research’s advanced wound dressing products industry databook is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

Foam Dressings Market Insights

The global foam dressings market generated over USD 1.7 Billion revenue in 2022 and is projected to expand at a CAGR of around 4.71% during the forecast period. The demand for foam dressing products is increasing owing to increasing burn cases, various ulcers, open wounds, and rising surgical cases across the globe. Furthermore, diabetes is expected to be a major factor causing wounds. Thus, a rise in the number of people suffering from diabetes is anticipated to drive the market. For instance, International Diabetes Federation projected the number of diabetic patients to be 61 million in 2021.
North America dominated the foam dressing market and accounted for a revenue share of 45.4% in 2021. The segment is expected to witness a considerable growth rate over the forecast period. The growth of the market is primarily driven by the vast population base and growing patient pool in nations like the U.S., and Canada. Additionally, because diabetic people are more likely to sustain chronic wounds, a rise in the diabetic population is likely to surge the demand for foam dressing supplies in this region.

 

Hydrocolloid Dressings Market Insights

The global hydrocolloid dressings market generated over USD 1.3 Billion revenue in 2022 and is projected to expand at a CAGR of around 5.01% during the forecast period. The market is primarily driven by the rising prevalence of chronic and acute wounds. For instance, according to recent estimates published in NCBI (2017), chronic wounds impact around 5.7 million people in the U.S. Similarly, the Independent Diabetes Trust in the U.K. claimed in its report (2019) that each year, around 115,000 people get diabetic foot ulcers, while 278,000 people are treated for venous leg ulcers. Moreover, the increased prevalence of severe burn injuries will boost the market growth. According to ebmedicine.net, about 265,000 individuals worldwide die as a result of thermal burns.

 

North America held the largest revenue share of 45.3% in 2021 and is expected to witness a steady CAGR over the forecast period. The region’s dominance is due to the rising prevalence of chronic wounds, higher treatment costs, and availability of appropriate reimbursement programs in the U.S. and Canada. Asia Pacific is estimated to witness the highest CAGR over the forecast period. The market is steadily increasing, offering several opportunities for the introduction of new products.

Film Dressings Market Insights

The global film dressings market generated over USD 1.5 Billion revenue in 2022 and is projected to expand at a CAGR of around 4.57% during the forecast period. The increasing prevalence of chronic and acute wounds is the key factor driving the film dressing market. For instance, Healogics, LLC in 2022 stated that around 7.0 million Americans are living with a chronic wound. Similarly, according to the article published in the African Journal of Health Sciences Volume, 2020, the prevalence of diabetic foot ulcers is highest is Belgium at 16.6% followed by Canada at 14.6%, USA and North America at 13.0% while Asia, Europe, and Africa had a prevalence of only 5.5%, 5.1%, and 7.2% respectively.

 

Order your copy of the Free Sample of Advanced Wound Dressing Products Industry Data Book, published by Grand View Research

 

Alginate Dressings Market insights

The global alginate dressings market generated over USD 902.9 Million revenue in 2022 and is projected to expand at a CAGR of around 4.13% during the forecast period. The rising incidence of chronic and acute wounds is the major factor driving the industry. For instance, according to recent estimates published in NCBI (2022), the annual incidence rate of diabetic foot ulcers globally was expected to be between 9.1 million to 26.1 million. Similarly, as per the Independent Diabetes Trust in the U.K. asserted in its report (2019) that while 278,000 people are treated for venous leg ulcers, around 115,000 people annually develop diabetic foot ulcers.

North America dominated the global industry with the largest share of more than 45.40% in 2021 and is expected to witness a considerable growth rate over the forecast period. The region’s dominance can be attributed to the increasing prevalence of chronic wounds, higher treatment costs, and the availability of appropriate reimbursement programs in the U.S. and Canada. According to an article published by the NCBI, the prevalence of diabetic foot ulcers among the population in the U.S. was roughly 13%.

Hydrogel Dressings Market Insights

 

The global hydrogel dressings market generated over USD 883.8 Million revenue in 2022 and is projected to expand at a CAGR of around 4.30% during the forecast period. The demand for hydrogel dressing is projected to increase due to rising chronic & acute wound population. Additionally, as the geriatric population has a slow healing ability, an increase in the number of elderly people is projected to enhance the use of hydrogel dressing. For instance, the U.S. Census Bureau reports 2012, the population of adults, aged 65 and over was around 43.1 million in 2012 and is projected to increase to over 92.0 million by 2060. Similar to this, the United Nations Population Fund (UNFPA) Asia and the Pacific estimates, by 2050, about one in every four people in the Asia Pacific region will be over 60, which is anticipated to boost the hydrogel dressing market.

 

North America dominated the hydrogel dressing market with a revenue share of 45.4% in 2021 and is expected to witness a considerable growth rate in the forecast period. The large population bases and expanding patient pools in countries like the U.S. and Canada are the main factors driving the expansion of the hydrogel dressing industry in this area. Additionally, the growing diabetic population is projected to drive increased demand for hydrogel dressing supplies in this area because diabetics are more likely to develop chronic wounds.

 

Collagen Dressings Market Insights

The global collagen dressings market generated over USD 691.7 Million revenue in 2022 and is projected to expand at a CAGR of around 3.77% during the forecast period. The demand for collagen dressing is driven by the rise in number of chronic disease patients worldwide. Additionally, an increase in the number of elderly populations is anticipated to boost the market as the geriatric population shows sedate healing ability. For instance, according to the U.S. Census Bureau, the number of people aged 65 and above was approximately 46.2 million in 2014 and is expected to reach over 98 million by 2060. Similarly, as per the United Nations Population Fund (UNFPA) Asia and the Pacific, by 2050, around one in every fourth person in the Asia Pacific region is expected to be above the age of 60, which is expected to fuel the market for collagen dressing over the period.

 

Go through the table of content of Advanced Wound Dressing Products Industry Data Book to get a better understanding of the Coverage & Scope of the study.

 

Advanced Wound Dressing Products Industry Data Book Competitive Landscape

The market is highly fragmented in nature with the presence of several small and large manufacturers. Competitive rivalry and degree of competition in the wound market is expected to intensify over the forecast period due to the presence of many players in the market. Furthermore, leading players are involved in collaborations, product launches, mergers and acquisitions to strengthen their product portfolios.

 

Key players operating in the advanced wound dressing products industry are –

• Smith & Nephew
• Molnlycke Health Care AB
• ConvaTec Group PLC
• Baxter International
• URGO Medical
• Coloplast Corp.
• Medtronic
• 3M
• Derma Sciences Inc. (Integra LifeSciences)
• Medline Industries

 

Patient Monitoring Devices Industry To Grow Due To Rapid Advancements In At-Home Treatments For Chronic Diseases

  

Patient monitoring devices industry data book covers remote patient monitoring, vital sign monitoring devices, blood pressure monitoring devices and multiparameter patient monitoring system market.

The global patient monitoring devices industry size was valued at USD 29.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 10.0% from 2023 to 2030.

The patient monitoring devices industry databook compiled by Grand View Research is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

 

Remote Patient Monitoring System Market Insights

The global remote patient monitoring devices market size was estimated at USD 4.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 18.5% from 2023 to 2030. COVID-19 has caused a significant impact on the industry. The remote monitoring systems serve with improved chronic disease management including early warning signs and progress tracker, thus boosting its demand at a global level. Chronic conditions account for 90% of the healthcare costs in the U.S. annually. This can be prevented by timely assistance provided to patients using a remote monitoring system.

An increase in the geriatric population in both developed and developing nations is expected to propel the remote patient monitoring devices market. Currently, there are over 40 million people in the U.S. alone above 65 years and the number is expected to double by 2050. Japan provides potential growth opportunities to this market due to the presence of the highest geriatric population in the country. According to WHO, the percentage of the geriatric population is expected to reach 22.0% by 2050. Aging is considered the foremost risk factor for chronic conditions. Thus, the increasing geriatric population, which is at a higher risk of chronic conditions such as diabetes, cardiovascular disorders, and sleep disorders, is expected to boost the market growth.

Vital Sign Monitoring Devices Market Insights

The global vital sign monitoring devices market size was valued at USD 9.2 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.4% from 2023 to 2030. Constant innovation in products, increasing demand for home healthcare services, rising number of healthcare settings, primarily hospitals, and rising prevalence of chronic disorders are key drivers responsible for the lucrative growth of the industry. Vital signs monitoring devices have evolved over a short duration of time from individual devices measuring blood pressure (BP), pulse, and temperature to a combined all-in-one device. In addition, there has been an increasing number of innovations in this product category, which is fueling the growth of products in this category.

 

North America dominated the global industry in 2022 and accounted for the largest share of more than 41.3% of the overall revenue. The region is likely to expand further at a steady CAGR maintaining its leading position throughout the forecast period. The growing geriatric population, rising occurrences of interminable disorders, and developing interest in remote and wireless devices combined with streamlined coverage policies are the main considerations credited to its share. The region also has high awareness and access to healthcare services with strong reimbursement coverage for essential medical devices, thereby leading to high demand.

 

 

Order your copy of the Free Sample of “Patient Monitoring Devices Industry Data Book - Remote Patient Monitoring, Vital Sign Monitoring Devices, Blood Pressure Monitoring Devices and Multiparameter Patient Monitoring System Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

 

Blood Pressure Monitoring Devices Market insights

 

The global blood pressure monitoring devices market size was valued at USD 3.8 billion in 2022 and is expected to expand at a CAGR of 9.6% from 2023 to 2030. Increasing incidences of hypertension due to changing lifestyles are the key factor attributed to the growth of the market over the forecast period. According to estimates published by the World Health Organization (WHO) in 2019, around 1.28 billion people around the globe have hypertension, which is a major cause of premature death worldwide. The demand for BP monitors is very high on account of the growing geriatric population base and increasing risk of lifestyle-associated disorders among a wide population base due to the rising incidences of obesity & sedentary lifestyle.

 

North America held the largest revenue share of more than 39.60% in 2022 as it has a highly regulated & developed healthcare infrastructure. Increasing investments in the development of accurate and effective BP monitors is the key factor expected to contribute to the market growth of BP monitoring devices in the coming years. Moreover, new product launches along with technological advancements are further expected to fuel the industry's growth. For instance, in February 2020, Hillrom announced the commercial launch of a new device, the Welch Allyn Spot Vital Signs 4400, which is an easy-to-use next-generation vital signs device used to improve hypertension detection in ambulatory & emergency department settings. Asia-Pacific, on the other hand, is expected to expand at the fastest CAGR over the forecast period.

 

Multiparameter Patient Monitoring System Market Insights

 

The global multiparameter patient monitoring systems market size was valued at USD 11.5 billion in 2022 and is expected to expand at a CAGR of 5.7% from 2023 to 2030. The market growth is primarily driven by the increasing demand for early diagnosis and treatment of chronic illnesses, the growing need for real-time patient monitors in critical care units, utilizing data points for enhanced clinical decisions, and providing hospital-like care in home care settings. The growth trajectory faced a few obstacles during the covid-19 pandemic. According to the CDC, in March 2020, regulators & health authorities ordered all private clinics and ambulatory care centers to stop screening patients, except for emergency procedures, resulting in high revenue loss across the health sector. Despite such obstacles, the COVID-19 epidemic has had a positive effect on the multiparameter monitoring devices industry.

North America dominated the global market and accounted for 41.6% of the total share in 2022 owing to the higher healthcare expenditure, growing initiatives to offer advanced patient monitoring products, and private-public partnerships. In addition, the rise in the prevalence of chronic diseases and the launch of supportive reimbursement programs are vital factors governing the growth of the market in this region.

Asia Pacific region is expected to witness the fastest CAGR of 6.4% over the forecast period. The growing aging population, increasing chronic disease burden, advancement in healthcare infrastructure, and healthcare digitization are anticipated to fuel regional market growth. For instance, more than 300 million people in China have chronic diseases. Additionally, China is the leading producer of low-cost electronic chips and products. Hence, it is projected to attract investors in China, thereby contributing to market growth.

Go through the table of content of Patient Monitoring Devices Industry Data Book to get a better understanding of the Coverage & Scope of the study.

 

Patient Monitoring Devices Industry Data Book Competitive Landscape

The industry growth is directly associated with the rising investments by manufacturers in the development of cost-effective, innovative products, and the rising prevalence of chronic diseases. The industry is marked by the presence of various industry players. The market is highly fragmented and competitive in nature.

 

Key players operating in the Patient Monitoring Devices industry are –

• Honeywell
• Telecare
• Roche
• Philips Healthcare
• Bosch
• Biotronik
• Koninklijke Philips N.V.
• GE Healthcare
• Medtronic
• Masimo Corporation
• Smiths Medical 

Blood Glucose Meters Industry To Be Driven By Growing Geriatric Population And Rising Incidence Of Diabetes

  

Blood Glucose Meters Industry Data Book Covers Point-of-care Glucose Testing Devices, Self-Monitoring & Continuous Blood Glucose Monitors Market.

The global blood glucose meters industry was valued at USD 15.80 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2030.

Grand View Research’s blood glucose meters industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

 

Point-of-care Glucose Testing Devices Market Insights

The global point-of-care glucose testing market size was valued at USD 3.27 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 3.7% from 2023 to 2030. The growing geriatric population, the ability of point-of-care (POC) diagnostic tests to deliver immediate results, thus providing improved patient care, and rising market penetration of electronic medical records (EMRs) are among the high-impact rendering drivers of this market. The shortage of skilled staff, especially in the field of diagnostics, is also expected to increase the market penetration of glucose POC diagnostic products.

 

The healthcare industry is emphasizing on shorter hospital stays, better acute care, and expansion of outlying surgical centers, which has consequently increased the demand for STAT testing. POC management solutions allow patients and healthcare providers to easily collect, share, and manage specimens to meet the regulatory requirements.
North America dominated the global market in 2022. The regional market accounted for the largest share of over 40.3% of the overall revenue in the same year. It is expected to maintain its lead even during the forecast period. This region is home to several key market players, such as Abbott, Nova Biomedical, and Prodigy Diabetes Care, LLC. This has increased the availability of glucose testing products, thereby contributing to the revenue generation of the regional market. In addition, higher healthcare expenditure by governments on diabetes management is one of the factors responsible for the regional market growth.

 

Blood Glucose Monitoring Devices Market insights

 

The global blood glucose monitoring devices market generated over USD 12.53 billion revenue in 2022 and is projected to expand at a CAGR of around 8.1% during the forecast period to reach USD 23.15 billion by 2030. The key drivers of the market are the rising incidence of diabetes and the increasing geriatric population prone to diabetes. The market growth is further propelled by the increasing awareness regarding diabetes preventive care and new product launches. Diabetes is a serious and growing problem globally, where the inefficiency of the pancreas to produce insulin results in an increase in blood glucose levels. According to the International Diabetes Federation, in 2021, around 537 Million people were diagnosed with diabetes, this number is expected to increase to 643 Million by 2030 and 783 Million by 2045.

 

North America led the market with a revenue share of over 38.0% in 2022 owing to its well-established healthcare sector. The increasing prevalence of obesity, high cost of treatment, technological advancements, and new product launches are also expected to drive the regional market. Europe is expected to capture a significant revenue share over the forecast period due to an increase in the geriatric population, which is prone to diabetes. Moreover, improvements in the healthcare sector and the implementation of advanced medical products are augmenting the demand for BGMs in the region.

Asia Pacific is projected to be a lucrative region over the forecast period. Improvements in healthcare facilities and reimbursement policies in developing economies are key factors aiding the growth in this region. China spearheaded the APAC region in 2022 owing to its large diabetes population and rapid economic growth. Furthermore, an increase in awareness regarding diabetes preventive care is augmenting the market growth.

 

Order your copy of the Free Sample of “Blood Glucose Meters Industry Data Book - Point-of-care Glucose Testing Devices, Self-Monitoring & Continuous Blood Glucose Monitors Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

 

Blood Glucose Meters Market – Global Industry Segmentation

 

Blood Glucose Meters By Product

 

• Blood Glucose Monitoring Devices
o Self-Monitoring Devices
o Continuous blood glucose monitoring devices
• Point-of-care glucose testing devices

Blood Glucose Meters By End-user

• Hospital
• Home setting
• Diagnostic center

Blood Glucose Meters By Region

• North America
o U.S.
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Russia
o Ukraine
o Belarus
o Turkey
o Rest of Europe
• APAC
o China
o Japan
o India
o South Korea
o Australia
o Rest of APAC
• Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of Latin America
• MEA
o South Africa
o Saudi Arabia
o UAE
o Rest of MEA

 

Go through the table of content of Blood Glucose Meters Industry Data Book to get a better understanding of the Coverage & Scope of the study.

 

Blood Glucose Meters Industry Data Book Competitive Landscape

 

Technological advancements: especially in case of biosensors, Bluetooth integration, & real-time alerts, and price competitiveness are two of the major strategies mostly focused on by the major market players. Each new product is designed to be easier to use by its antecedents and laced with connectivity. Increasing awareness of advanced diabetes management tools is among the top priority of market players.

 

Key players operating in the Blood Glucose Meters industry are –

• Abbott Laboratories
• Medtronic plc
• F. Hoffmann-La Roche Ltd
• Ascensia Diabetes Care
• Dexcom, Inc.
• Sanofi
• Novo Nordisk
• Insulet Corporation
• Ypsomed Holdings
• Glysens Incorporated

Neurodegenerative Disease Therapeutics Industry To Grow Due To The Strong Product Pipeline Of Disease-Modifying Therapies

  

 

Neurodegenerative Disease Therapeutics Industry Data Book Covers Parkinson’s Disease Treatment and Alzheimer's Therapeutics Market.

 

The global neurodegenerative disease industry combine to account for USD 8.33 billion revenue in 2021, which is expected to reach USD 28.15 billion by 2030, growing at a cumulative rate of 15.6% over the forecast period.

 

Grand View Research’s neurodegenerative disease therapeutics industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.The following data points will be included in the final product offering in two reports and one sector report overview.

 

Parkinson’s Disease Treatment Market Insights

The global Parkinson’s disease treatment market size was valued at USD 4.28 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 12.1% from 2022 to 2030. The increasing geriatric population, which is exposed to a high risk of developing Parkinson’s Disease (PD), the high burden of PD in western countries, and the strong product pipeline of disease-modifying therapies are anticipated to be major drivers for the industry. According to the International Parkinson and Movement Disorder Society, in 2020, around 9.4 million individuals had PD worldwide. Moreover, PD affects around 1% of the total population over the age of 60 years, which rises to 5% for the population over the age of 85 years.

North America dominated the global industry with a maximum revenue share of 37.90% in 2021. This dominance can be attributed to the presence of leading players in the region, such as AbbVie Inc., Merck & Co. Inc., Amneal Pharmaceuticals LLC., and Sunovion Pharmaceuticals Inc. These players support growth by introducing new PD symptom management products. For instance, in May 2020, the U.S. FDA approved Kynmobi developed by Sunovion Pharmaceuticals Inc., to treat off-episodes in patients with PD. Furthermore, extensive research in the field of PD in the region is anticipated to positively contribute to the market growth.

 

Alzheimer's Therapeutics Market insights

The global alzheimer’s therapeutics market size was valued at USD 4.05 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 19.99% from 2023 to 2030. The rising prevalence of Alzheimer’s Disease (AD) and approval of disease-modifying therapies are expected to fuel market growth. According to the NCBI, in 2021, about 6.2 million people aged 65 and above living in America were suffering from Alzheimer’s disease, which is estimated to increase to around 13.8 million by 2060. Women are more prone to be diagnosed with Alzheimer’s disease than men due to the longer life expectancy of women. Moreover, Alzheimer’s disease is becoming the most common cause of death in neurodegenerative diseases and a common cause of physical disability that require immediate treatment.

North America dominated the market with a share of over 40.79% in 2022 and is anticipated to grow at a significant rate over the forecast period. The growing research for the treatment of Alzheimer’s is propelling the market growth. In June 2021, Eisai Co., Ltd. and Biogen’s product lecanemab (BAN2401), an anti-amyloid beta protofibril antibody for treating Alzheimer’s disease, was granted the Breakthrough Therapy designation by the U.S. FDA. Moreover, the increasing government initiatives and funding are expected to boost the growth of the market.

The Asia Pacific region is expected to emerge as the fastest-growing region over the forecast period owing to increasing awareness among people and the increasing research activities to develop novel drugs to treat AD. In 2022, there are around 487,500 Australians living with dementia and this number is expected to increase to 1.1 million by 2058. Dementia is the second leading cause of death in Australia.

 

Order your copy of the Free Sample of “Neurodegenerative Disease Therapeutics Industry Data Book - Parkinson’s Disease Treatment and Alzheimer's Therapeutics Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

 

 

Neurodegenerative Disease Therapeutics Market – Global Industry Segmentation

 

Neurodegenerative Disease Therapeutics Industry, by Drug Class

• Parkinson’s Disease Treatment
• Alzheimer’s Therapeutics


Neurodegenerative Disease Therapeutics Industry, By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• E-commerce

 

Neurodegenerative Disease Therapeutics Industry, By Region

• North America
o U.S.
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Russia
o Denmark
o Norway
o Sweden
o Rest of Europe
• APAC
o China
o Japan
o India
o South Korea
o Australia
o Singapore
o Thailand
o Rest of APAC
• Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin America
• MEA
o South Africa
o Saudi Arabia
o UAE
o Kuwait
o Rest of MEA

Go through the table of content of Neurodegenerative Disease Therapeutics Industry Data Book to get a better understanding of the Coverage & Scope of the study.

 

 

Neurodegenerative Disease Therapeutics Industry Data Book Competitive Landscape

Competitive rivalry in this market is likely to be high due to increasing number of mergers, acquisitions, and partnerships undertaken by major players globally. Many established and clinical-stage pharmaceutical companies are involved in the development of novel therapies & drugs to target people with unmet clinical needs.

 

Key players operating in the Neurodegenerative Disease Therapeutics industry are –

• Eisai Co., Ltd.
• AbbVie Inc. (Allergan Plc.)
• Merck & Co., Inc.
• Adamas Pharmaceuticals, Inc.
• Novartis AG,H. Lundbeck A/S
• Cerevel Therapeutics
• Biogen
• Daiichi Sankyo Company, Limited
• F. Hoffmann La Roche Ltd.
• TauRx Pharmaceuticals Ltd.
• Johnson & Johnson Services, Inc.
• AC Immune
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline plc. (GSK). 

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Check out more Industry Data Books, published by Grand View Research

 

 

 

Magnetic Resonance Imaging Scanners and Accessories Industry Data Book | Analysis and Trends Report to 2030

  

Magnetic Resonance Imaging Scanners and Accessories Industry Data Book Covers Magnetic Resonance Imaging, MRI Coils & Motion Tracking Systems Market.

 

Grand View Research’s magnetic resonance imaging scanners and accessories industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.

 

Magnetic Resonance Imaging Market Insights

The global magnetic resonance imaging (MRI) market size was valued at USD 5.26 billion in 2022 and is anticipated to grow at a CAGR of 6.8% over the forecast period. MRI is an efficient diagnostic machine for identifying diseases related to spine lesions, tumors, and stroke impacting the area of blood vessels and brain. The increasing prevalence of these diseases is expected to play an important role in the market growth. For instance, as per the International Agency for Research on Cancer, in 2020, 19,292,789 new cancer cases were recorded globally. In addition to this the growing demand for quick and effective diagnostic procedures is expected to contribute towards the adoption of MRI machines.

North America dominated the global market by capturing over 37% of the global MRI market in 2021. Increasing incidence of chronic diseases in this region, which includes breast cancer, cardiovascular disorders, and neurological diseases is creating a demand for imaging analysis. The region is expected to maintain its dominance throughout the forecast period. Technological innovations coupled with the growing incidence of chronic conditions is anticipated to spur the growth of MRI during the forecast period.

 

MRI Coils Market Insights

The global magnetic resonance imaging coils market size was valued at USD 7.98 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.7% from 2023 to 2030. The market is being driven by several factors, including increasing demand for diagnostic imaging procedures, technological advancements in magnetic resonance imaging (MRI) coil design, and the rising prevalence of chronic diseases including neurological disorders, cancer, and cardiovascular diseases. As per the WHO estimates, cardiovascular diseases are a leading cause of death, taking 17.9 million lives each year. This, in turn, is anticipated to propel the growth of enhanced imaging diagnostics, thus, fueling the growth of the industry.

North America dominated the market globally and held the highest revenue share of 27.6% in 2022. Technological advancements have led to the development of faster and more powerful machines that produce higher-quality images, which has increased the demand for MRI in the diagnosis and treatment of various medical conditions. The prevalence of chronic diseases is also increasing, leading to a higher demand for imaging services.

Europe also held a significant share in the market this can be attributed to factors such as an increase in the prevalence of chronic disorders, and rapid adoption of advanced technologies, According to the European heart network, each year, cardiovascular diseases cause around 3.9 million deaths in Europe which are fueling the demand of MRI Coils.

 

Order your copy of the Free Sample of “Magnetic Resonance Imaging Scanners and Accessories Industry Data Book - Magnetic Resonance Imaging, MRI Coils & Motion Tracking Systems Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

 

Motion Tracking Systems Market Insights

The global MRI motion tracking systems market size was valued at USD 2.7 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 20.76% from 2022 to 2030. MRI is an efficient tool to detect aneurysms, tumors, and abnormalities in the brain and body. As per OECD, in 2020 the number of MRI units installed in the U.S. was 34.54 per million population. However, it is the growing need of the hour to develop a system that improves the stability of the image captured by MRI and reduces unnecessary rescans. Scans conducted for patients needing sedation such as pediatrics and geriatric patients with involuntary motions, often record motion artifacts, creating unclear diagnostic scans. Hence, motion tracking systems, are used to tackle such issues. 

 

North America dominated the global market by capturing over 58.3% of the revenue share in 2021. Increased adoption of MRI scans over other diagnostic modalities, high healthcare GDP, stringent diagnostic regulation, and the presence of numerous research institutes working to develop more effective systems.
The APAC region accounts for a higher CAGR of 40.8% in the forecast period. This high-growth region holds the potential to develop local systems at a minimized cost in the future and increased contracts to contract research manufacturers from manufacturers of developed nations. Latin America and the Middle East and Africa markets generated no revenue from 2020 to 2021. However, it is said to improve by 2022 as local players would enter the market.

 

The APAC region accounts for a higher CAGR of 40.8% in the forecast period. This high-growth region holds the potential to develop local systems at a minimized cost in the future and increased contracts to contract research manufacturers from manufacturers of developed nations. Latin America and the Middle East and Africa markets generated no revenue from 2020 to 2021. However, it is said to improve by 2022 as local players would enter the market.

 

Go through the table of content of Customer Relationship Management Industry Data Book to get a better understanding of the Coverage & Scope of the study.

 

Magnetic Resonance Imaging Scanners and Accessories Industry Data Book Competitive Landscape

 

The high price is one of the most impeding factors for the sales of these systems. The major players are focusing on minimizing the prices for medium-strength MRI systems using various methods. Technological advancements in manufacturing and the high influx of these systems in the market is expected to bring the prices down in the upcoming years.

 

Key players operating in the Magnetic Resonance Imaging Scanners and Accessories Industry are –

• GE Healthcare
• Siemens Healthineers
• Toshiba Corporation
• Aurora Imaging Technologies, Inc.
• Koninklijke Philips N.V.
• Esaote SPA
• Sanrad Medical Systems Pvt ltd
• Fujifilm
• MR Instruments, Inc.
• RAPID MR International, LLC
• ScanMed
• Canon Medical Systems Corporation
• Hologic Inc.
• Bruker
• TracInnovations
• Kineticor
• Metria Innovations